top of page

Searching for novel targets in IO with the co-founder and CEO of Cartography Biosciences

Kevin Parker describes how Cartography has been building an antigen map over previous years in search of novel targets in a field otherwise prone to overcrowding.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page